Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?

Am J Respir Crit Care Med. 2023 Nov 15;208(10):1143-1144. doi: 10.1164/rccm.202307-1301LE.

Authors

Jingcun Wang¹, Qiming Gan¹, Haojie Zhang¹, Qiuyun Xing², Yanjuan Wu¹, Xiaofen Su¹, Nuofu Zhang¹, Kang Wu¹

Affiliations

¹ Sleep Medicine Center, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; and.
² Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Doxycycline* / therapeutic use
Humans
Pulmonary Disease, Chronic Obstructive*

Substances

Doxycycline